[Inhaled loxapine for emergency treatment of agitated patients with borderline personality disorder : A series of five cases].
暂无分享,去创建一个
H. Frieling | M. Wollmer | T. Krüger | K. G. Kahl | S. Jung | P. Negt
[1] M. Wollmer,et al. The Hamburg-Hannover Agitation Scale (H2A): Development and validation of a self-assessment tool for symptoms of agitation. , 2015, Journal of psychiatric research.
[2] G. Juckel,et al. [Acute agitation conditions]. , 2015, Der Nervenarzt.
[3] M. Müller,et al. Pharmakotherapie von psychiatrischen Akut- und Notfallsituationen , 2015, Der Nervenarzt.
[4] E. Meltzer,et al. Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials. , 2014, Journal of aerosol medicine and pulmonary drug delivery.
[5] L. Salvador-Carulla,et al. Cost of borderline personality disorder in Catalonia (Spain) , 2014, European Psychiatry.
[6] P. Marschall,et al. Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care. , 2014, Behaviour research and therapy.
[7] G. Fitzmaurice,et al. Pro Re Nata (As Needed) Psychotropic Medication Use in Patients With Borderline Personality Disorder and Subjects With Other Personality Disorders Over 14 Years of Prospective Follow-Up , 2014, Journal of clinical psychopharmacology.
[8] K. Lieb,et al. Pharmacotherapy for Borderline Personality Disorder—Current Evidence and Recent Trends , 2014, Current Psychiatry Reports.
[9] M. Mimura,et al. Absence of evidence that the pro re nata regimen confers benefit: a review of the studies , 2013, International clinical psychopharmacology.
[10] G. Juckel. [Inhalative loxapine: old tried and trusted medication with new indications]. , 2013, Der Nervenarzt.
[11] J. Kehne,et al. Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo‐controlled clinical trial with inhaled loxapine , 2012, Bipolar disorders.
[12] G. Currier,et al. The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup , 2012, The western journal of emergency medicine.
[13] D. Spyker,et al. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial. , 2011, The Journal of clinical psychiatry.
[14] J. Guelfi,et al. Personnalité borderline, automutilations et suicide : revue de la littérature , 2008 .
[15] T. Gallarda,et al. [Paradoxical aggressive reactions to benzodiazepine use: a review]. , 2008, L'Encephale.
[16] S. Marder. A review of agitation in mental illness: treatment guidelines and current therapies. , 2006, The Journal of clinical psychiatry.
[17] V. Pérez,et al. Injectable Atypical Antipsychotics for Agitation in Borderline Personality Disorder , 2006, Pharmacopsychiatry.
[18] G. Currier,et al. The expert consensus guideline series. Treatment of behavioral emergencies 2005. , 2005, Journal of psychiatric practice.
[19] M. Allen,et al. What Do Consumers Say They Want and Need During a Psychiatric Emergency? , 2003, Journal of psychiatric practice.
[20] Gardner Dl,et al. Alprazolam-induced dyscontrol in borderline personality disorder. , 1985 .